Albert David
NSE: ALBERTDAVD · ISIN INE155C01010 · Healthcare
₹803.00+9.15 (+1.15%)
Monday 9 November, 11:59 IST. Delayed. Source: Yahoo Finance.
Price chart
₹803.00 +9.15 (+1.15%) today
The day
- Previous close
- ₹793.85
- Open
- ₹808.90
- Day high
- ₹808.90
- Day low
- ₹766.05
Listed on NSE since 14 June 2016.
Key numbers
- Market value
- ₹444.36 Cr
- P/E (trailing)
- 19.70
- EPS (trailing)
- ₹39.53
- Price to book
- 1.13
- Dividend yield
- 0.64%
- Debt to equity
- 0.08
- Profit margin
- 6.2%
- Beta
- 0.41
- Volume today
- 980
- Average volume
- 6,009
Source: Yahoo Finance. Ratios use the latest reported (trailing twelve-month) figures.
Revenue and profit
| Year | Revenue | Net profit |
|---|---|---|
| FY23 | ₹340.01 Cr | ₹36.17 Cr |
| FY24 | ₹360.26 Cr | ₹75.42 Cr |
| FY25 | ₹343.25 Cr | ₹17.20 Cr |
| FY26 | ₹329.36 Cr | ₹-1.49 Cr |
Source: Yahoo Finance, from annual reports. Consolidated where reported.
Quarterly results
| Quarter | Revenue | Net profit | Profit vs year ago |
|---|---|---|---|
| Q1 FY27Apr–Jun 2026 | ₹101 Cr | ₹32 Cr | +303.1% |
| Q4 FY26Jan–Mar 2026Audited | ₹86 Cr | ₹-21 Cr | – |
| Q3 FY26Oct–Dec 2025 | ₹90 Cr | ₹15 Cr | – |
| Q2 FY26Jul–Sep 2025 | ₹87 Cr | ₹-3 Cr | – |
| Q1 FY26Apr–Jun 2025 | ₹71 Cr | ₹8 Cr | – |
| Q4 FY25Jan–Mar 2025Audited | ₹75 Cr | ₹-10 Cr | – |
Source: Albert David’s results filed with NSE, standalone (the company alone). Net profit is the share of Albert David’s own shareholders where the filing separates it. Profit vs year ago compares with the same quarter a year earlier; – where that quarter is not on file or made a loss.
Download results (zip) A spreadsheet of the quarterly results and balance sheets, with the original filings from NSE.
Balance sheet
| As on | March 2026 | September 2025 |
|---|---|---|
| Fixed assets | ₹120 Cr | ₹100 Cr |
| Investments | ₹228 Cr | ₹277 Cr |
| Inventories | ₹58 Cr | ₹51 Cr |
| Owed by customers | ₹34 Cr | ₹42 Cr |
| Cash and equivalents | ₹29.91 L | ₹89.33 L |
| Total assets | ₹519 Cr | ₹533 Cr |
| Borrowings | ₹28 Cr | ₹41 Cr |
| Total liabilities | ₹128 Cr | ₹139 Cr |
| Shareholders’ equity | ₹392 Cr | ₹394 Cr |
Source: Albert David’s half-yearly statements of assets and liabilities filed with NSE, standalone. Companies file these every September and March.
About Albert David
Albert David Limited manufactures and trades in pharmaceutical formulations, infusion solutions, herbal dosage forms, and bulk drugs in India and internationally. It offers formulations for parenterals, oral/enterals, topical agents, aerosol, and vision care products. The company exports its products to Latin American, South East Asian and North African countries Albert David Limited was incorporated in 1938 and is headquartered in Kolkata, India.
- Industry
- Drug Manufacturers - Specialty & Generic
- Based in
- Kolkata
- Employees
- 1,476
Company website · Profile: Yahoo Finance
In the news
All newsNo headlines name Albert David in the last day or two.
Dividends and corporate actions
All companies- Dividend - Rs 5 Per Share
Dividend · ex-date 30 July 2026
- Dividend - Rs 5 Per Share
Dividend · ex-date 25 July 2025
- Dividend - Rs 11.50 Per Share
Dividend · ex-date 2 August 2024
- Annual General Meeting
Action · ex-date 2 August 2024
- Dividend - Rs 9 Per Share
Dividend · ex-date 3 August 2023
- Annual General Meeting
Action · ex-date 3 August 2023
- Annual General Meeting/Dividend - Rs 9 Per Share
Dividend · ex-date 1 August 2022
- Annual General Meeting
Action · ex-date 6 September 2021
Source: NSE. Latest first, 8 of 15.
Information only, not investment advice. Prices are delayed.